Malaysian Genomics Resource Centre Berhad (0155)

Overview

Malaysian Genomics Resource Centre Berhad, founded in 2004 and headquartered in Petaling Jaya, Malaysia, is an investment holding company with a global outreach, offering a vast array of services in genetics, genomics, immunotherapy, and biopharmaceutical fields. Its operations span across life sciences, including research and development, as well as the distribution and commercialization of healthcare products. Among its standout collaborations is the research partnership with Universiti Sains Malaysia, aimed at unraveling the genetic history and aging the ancient Penang Woman Skeleton through advanced Accelerator Mass Spectrometry dating techniques. Beyond its core scientific endeavors, the company is also actively involved in various business ventures, including capital market investments and general merchandising.

Products and Services

Genome Sequencing Services: Offering comprehensive genome sequencing solutions for a wide range of organisms, including humans, animals, plants, and microbes. Services cover whole genome and transcriptome sequencing, along with specialized options like metagenomics and metatranscriptomics.

Genome Analysis Services: Provides a suite of bioinformatics services, handling everything from quality analysis of reads to whole genome assembly, variation analysis, gene annotation, and complex analyses such as ChIP-Seq data processing, microRNA annotation and mutation analysis.

Trait Analysis Services: Focused on screening multiple samples to identify genetic markers within plant and animal genomes, facilitating improved traits in future generations.

Trio Sequencing Services: Offers a detailed examination of an individual's DNA, enhancing the understanding of genetic relationships and inheritance patterns within families.

Genetic Screening Services: Features Dtect, a comprehensive range of test panels designed to identify genetic markers in an individual's DNA that may indicate susceptibility to various conditions or diseases.

Cancer Immunotherapy Services: Provides immunotherapeutic options for treating a variety of cancer types, leveraging the body's immune system to fight cancer cells.

Life Sciences/Cell Laboratory Services: Engages in the research, development, and commercialization of biopharmaceutical products and services, including the supply of healthcare products and provision of various human health and general medical services.

Beauty Products and Precision Medicine: Distributes beauty products and develops precision medicine solutions, tailoring medical treatment to individual characteristics, needs, and preferences.

Capital Market and Derivative Instruments: Involves in investments and trading in capital market and derivative instruments, utilizing financial markets to further its business interests.

General Merchants: Acts as a general merchant, engaging in the sale and distribution of various products and services across different industries.